Sunshine Biopharma, Inc Contracts & Agreements
58 Contracts & Agreements
- Business Finance (44 contracts)
- Human Resources (5)
- Intellectual Property (2)
- Uncategorized (7)
- Employment Agreement, dated October 21, 2024, between the Company and Dr. Abderrazzak Merzouki (Filed With SEC on October 23, 2024)
- Employment Agreement, dated October 21, 2024, between the Company and Dr. Steve N. Slilaty (Filed With SEC on October 23, 2024)
- Employment Agreement, dated October 21, 2024, between the Company and Camille Sebaaly (Filed With SEC on October 23, 2024)
- Underwriting Agreement, dated February 13, 2024, by and between the Company and Aegis Capital Corp (Filed With SEC on February 15, 2024)
- Form of Series A Warrant (Filed With SEC on February 15, 2024)
- Form of Series B Warrant (Filed With SEC on February 15, 2024)
- May 2023 Warrant Purchase Agreement (Filed With SEC on February 12, 2024)
- Form of April 2022 Warrant Purchase Agreement (Filed With SEC on February 12, 2024)
- Form of Warrant Agency Agreement for this offering (Filed With SEC on February 9, 2024)
- Form of Underwriting Agreement (Filed With SEC on February 9, 2024)
- Form of Pre-Funded Warrant for this Offering (Filed With SEC on February 9, 2024)
- Form of Series A Warrant for this Offering (Filed With SEC on February 9, 2024)
- Form of Series B Warrant for this Offering (Filed With SEC on February 9, 2024)
- Amendment to Warrant Agent Agreement (Filed With SEC on October 20, 2023)
- Placement Agent Agreement dated May 12, 2023 (Filed With SEC on May 16, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on May 16, 2023)
- Form of Warrant (Filed With SEC on May 16, 2023)
- Form of Registration Rights Agreement (Filed With SEC on May 16, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on May 16, 2023)
- The License Agreement between the Company and the University of Arizona (Filed With SEC on February 28, 2023)
- Research Agreement between the Company and JGH (Filed With SEC on February 10, 2023)
- Share Purchase Agreement between Sunshine Biopharma, Inc., Malek Chamoun and Nora Pharma Inc (Filed With SEC on October 20, 2022)
- Employment Agreement between Sunshine Biopharma, Inc., Nora Pharma Inc. and Malek Chamoun (Filed With SEC on October 20, 2022)
- Form of Registration Rights Agreement (Filed With SEC on April 28, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on April 28, 2022)
- Form of Warrant (Filed With SEC on April 28, 2022)
- Form of Securities Purchase Agreement (Filed With SEC on April 28, 2022)
- Engagement Letter dated April 25, 2022 (Filed With SEC on April 28, 2022)
- Employment Agreement between Sunshine Biopharma, Inc. and Dr. Steve Slilaty (Filed With SEC on April 8, 2022)
- Description of Registrants Securities (Filed With SEC on March 21, 2022)
- Engagement Letter dated March 9, 2022, as amended (Filed With SEC on March 15, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on March 15, 2022)
- Form of Registration Rights Agreement (Filed With SEC on March 15, 2022)
- Form of Warrant (Filed With SEC on March 15, 2022)
- Form of Securities Purchase Agreement (Filed With SEC on March 15, 2022)
- Research Agreement, dated February 18, 2022, between the Company and the University (Filed With SEC on February 25, 2022)
- Warrant Agency Agreement between Sunshine Biopharma, Inc. and Equiniti Trust Company, dated February 17, 2022 (Filed With SEC on February 17, 2022)
- Underwriting Agreement between Sunshine Biopharma, Inc. and Aegis Capital Corp., dated February 15, 2022 (Filed With SEC on February 17, 2022)
- Form of Warrant (Filed With SEC on February 17, 2022)
- Form of Underwriting Agreement (Filed With SEC on February 14, 2022)
- Form of Warrant for offering (Filed With SEC on February 14, 2022)
- Form of Warrant for offering (Filed With SEC on February 9, 2022)
- Form of Underwriting Agreement (Filed With SEC on February 9, 2022)
- Form of Pre-Funded Warrant for offering (Filed With SEC on February 9, 2022)
- Form of Warrant Agent Agreement (Filed With SEC on February 9, 2022)
- Sponsored Research Agreement, dated October 6, 2020, between the Company and the University of Georgia Research Foundation, Inc (Filed With SEC on January 24, 2022)
- Financing Agreement with RB Capital Partners, Inc (Filed With SEC on September 15, 2020)
- Share Transfer Agreement with Atlas Pharma Inc., et al (Filed With SEC on July 19, 2019)
- Registration Rights Agreement dated September 10, 2018 by and between Sunshine Biopharma, Inc. and GHS Investments, LLC (Filed With SEC on September 14, 2018)
- Equity Financing Agreement dated September 10, 2018 by and between Sunshine Biopharma, Inc. and GHS Investments, LLC (Filed With SEC on September 14, 2018)
- Promissory Note issued by Sunshine Biopharma, Inc. in favor of GHS Investments LLC (Filed With SEC on September 14, 2018)
- AMENDMENT NO. 1 TO PATENT PURCHASE AGREEMENT By and Between SUNSHINE BIOPHARMA, INC. And ADVANOMICS CORPORATION Dated as of March 14, 2016 (Filed With SEC on March 14, 2016)
- AMENDMENT NO. 1 TO PATENT PURCHASE AGREEMENT By and Between SUNSHINE BIOPHARMA, INC. And ADVANOMICS CORPORATION Dated as of March 14, 2016 (Filed With SEC on March 14, 2016)
- Patent Purchase Agreement with Advanomics Corporation (Filed With SEC on December 28, 2015)
- PATENT PURCHASE AGREEMENT By and Between SUNSHINE BIOPHARMA, INC. And ADVANOMICS CORPORATION Dated as of October 8, 2015 PATENT PURCHASE AGREEMENT (Filed With SEC on October 9, 2015)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on April 28, 2014)
- INVESTMENT AGREEMENT (Filed With SEC on April 28, 2014)
- AMENDMENT 2 TO EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on December 27, 2011)
